Yueyi Deng Selected Research

Yueyi Deng Research Topics

Disease

7	Proteinuria 01/2023 - 05/2012
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 06/2013
5	Kidney Diseases (Kidney Disease) 06/2016 - 05/2012
4	Membranous Glomerulonephritis (Membranous Nephropathy) 10/2022 - 01/2012
4	IGA Glomerulonephritis (IGA Nephropathy) 12/2021 - 01/2013
4	Chronic Renal Insufficiency 03/2021 - 12/2013
3	Nephrotic Syndrome (Syndrome, Nephrotic) 10/2022 - 12/2013
3	Inflammation (Inflammations) 06/2021 - 01/2018
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2020 - 12/2013
2	Fibrosis (Cirrhosis) 01/2018 - 02/2014
2	Albuminuria 11/2017 - 10/2012
1	Hypercholesterolemia 01/2023
1	Hypertriglyceridemia 01/2023
1	Hyperlipidemias (Hyperlipidemia) 01/2023
1	Dyslipidemias (Dyslipidemia) 01/2023
1	Hypokalemia 12/2021
1	Overweight 07/2021
1	Rheumatoid Arthritis 06/2021
1	Experimental Arthritis 06/2021
1	Disease Progression 03/2021
1	Stroke (Strokes) 01/2020
1	Anemia 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Hypertension (High Blood Pressure) 06/2016
1	Hypertrophy 01/2014
1	Yin Deficiency (Yinxu) 06/2013
1	Fatigue 06/2013
1	Essential Hypertension 10/2012
1	AIDS-Associated Nephropathy (HIV-Associated Nephropathy) 05/2012
1	Renal Insufficiency (Renal Failure) 05/2012

Drug/Important Bio-Agent (IBA)

5	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2012
4	CreatinineIBA 01/2023 - 12/2013
3	LipidsIBA 10/2022 - 06/2016
3	puerarinIBA 01/2020 - 01/2014
2	Prednisone (Sone)FDA LinkGeneric 12/2021 - 12/2013
2	Therapeutic UsesIBA 03/2021 - 12/2013
2	Losartan (Cozaar)FDA LinkGeneric 01/2020 - 01/2014
1	Uric Acid (Urate)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	HDL CholesterolIBA 01/2023
1	Dialysis SolutionsIBA 12/2021
1	Leflunomide (Arava)FDA LinkGeneric 12/2021
1	PotassiumIBA 12/2021
1	Glycerides (Acylglycerol)IBA 07/2021
1	SphingomyelinsIBA 07/2021
1	Triglycerides (Triacylglycerol)IBA 07/2021
1	Docosahexaenoic AcidsIBA 07/2021
1	Nonesterified Fatty Acids (NEFA)IBA 07/2021
1	OsteoprotegerinIBA 06/2021
1	FlavonoidsIBA 06/2021
1	LigandsIBA 06/2021
1	CytokinesIBA 06/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	yishenIBA 01/2020
1	Plant ExtractsIBA 01/2020
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 10/2019
1	arctigeninIBA 10/2019
1	HematinicsIBA 01/2019
1	IronIBA 01/2019
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	Oxidoreductases (Dehydrogenase)IBA 11/2017
1	ResistinIBA 06/2016
1	AdipokinesIBA 06/2016
1	Type II Tumor Necrosis Factor ReceptorsIBA 06/2016
1	4-toluenesulfonyl fluoride (TSF)IBA 01/2015
1	tangshenIBA 01/2015
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2015
1	Serum AlbuminIBA 12/2013
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	shenqiIBA 12/2013
1	Herbal TeasIBA 06/2013
1	shenyan kangfuIBA 06/2013
1	Irbesartan FDA LinkGeneric 06/2013
1	TabletsIBA 06/2013
1	Nonprescription Drugs (Patent Medicines)IBA 06/2013
1	Histone Deacetylase InhibitorsIBA 04/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2013
1	Valsartan (Vals)FDA Link 10/2012
1	RoflumilastIBA 05/2012
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 05/2012
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 05/2012
1	Am 580 (Am580)IBA 05/2012
1	RetinoidsIBA 05/2012

Therapy/Procedure

4	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021 - 06/2013
3	Therapeutics 01/2021 - 12/2013
1	Renal Dialysis (Hemodialysis) 01/2019
1	Complementary Therapies (Alternative Medicine) 09/2015
1	Drug Therapy (Chemotherapy) 12/2013